| Disrupting LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation MC Gage, N Bécares, R Louie, KE Waddington, Y Zhang, TH Tittanegro, ... Proceedings of the National Academy of Sciences 115 (28), E6556-E6565, 2018 | 44 | 2018 |
| Disrupting LXR? phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation MC Gage, N Becares, R Louie, KE Waddington, Y Zhang, TH Tittanegro, ... PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF …, 0 | 44 | |
| Screening for PPAR non-agonist ligands followed by characterization of a hit, AM-879, with additional no-adipogenic and cdk5-mediated phosphorylation inhibition properties HV Ribeiro Filho, N Bernardi Videira, AV Bridi, TH Tittanegro, ... Frontiers in endocrinology 9, 11, 2018 | 31 | 2018 |
| Evaluating the role of antibiotics in patients admitted to hospital with decompensated cirrhosis: lessons from the ATTIRE trial. R Kutmutia, T Tittanegro, L China, E Forrest, Y Kallis, SD Ryder, G Wright, ... The American Journal of Gastroenterology, 2022 | 15 | 2022 |
| PPARγ S273 phosphorylation modifies the dynamics of coregulator proteins recruitment MMG Dias, FAH Batista, TH Tittanegro, AG de Oliveira, A Le Maire, ... Frontiers in endocrinology 11, 561256, 2020 | 12 | 2020 |
| Targeted albumin infusions do not improve systemic inflammation or cardiovascular function in decompensated cirrhosis L China, N Becares, C Rhead, T Tittanegro, N Freemantle, A O'Brien Clinical and translational gastroenterology 13 (5), e00476, 2022 | 9 | 2022 |
| Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway AA Maini, N Becares, L China, TH Tittanegro, A Patel, RPH De Maeyer, ... JHEP Reports 3 (6), 100332, 2021 | 8 | 2021 |
| Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial T Tittanegro, L China, E Forrest, Y Kallis, SD Ryder, G Wright, ... EClinicalMedicine 55, 101716, 2023 | 5 | 2023 |
| GQ‐130, a novel analogue of thiazolidinedione, improves obesity‐induced metabolic alterations in rats: Evidence for the involvement of PPARβ/δ pathway OA Silva, HV Ribeiro‐Filho, TM Avelino, TH Tittanegro, ACM Figueira, ... Clinical and Experimental Pharmacology and Physiology 47 (5), 798-808, 2020 | 3 | 2020 |
| Identificação dos mecanismos de fosforilação do PPAR gama e suas relações com o recrutamento de correpressores TH Tittanegro | 1 | 2018 |
| Lipidomics analyses of ATTIRE trial patients’ plasma at day 1 demonstrates that reduced cholesterol esterification predicts development of hospital acquired infection H Fuller, T Tittanegro, A Maini, L China, J Thorne, JB Moore, A O’Brien Journal of Hepatology 77 (Supplement 1), S104-S104, 2022 | | 2022 |
| PPARg S273 Phosphorylation Modifies the Dynamics of Coregulator Proteins Recruitment MMG Dias, FAH Batista, TH Tittanegro, AG de Oliveira, A Le Maire Nuclear Receptors and Coregulators in Metabolism and Immunity, 2022 | | 2022 |
| Plasma Soluble CD14 predicted development of hospital acquired infection in decompensated cirrhosis patients from the ATTIRE trial L CHINA, T TITTANEGRO, C RHEAD, NB SALLES, A O’BRIEN Alcohol 743, 89.7, 2021 | | 2021 |
| Investigating the potential association of elevated plasma Leukotriene B4 and survival in females in the ATTIRE trial TH Tittanegro, A Maini, L China, N Becares, N Freemantle, A O'Brien JOURNAL OF HEPATOLOGY 75, S452-S452, 2021 | | 2021 |
| Disrupting myeloid-specific LXRa phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation MC Gage, N Becares, R Louie, KE Waddington, Y Zhang, TH Tittanegro, ... PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF …, 2018 | | 2018 |
| Disrupting myeloid-specific LXRα phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation MC Gage, N Bécares-Salles, R Louie, K Waddington, Y Zhang, ... bioRxiv, 228783, 2017 | | 2017 |
